Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 54.50%476.26M | 68.26%503.22M | 58.49%470.41M | 26.44%1.28B | 21.39%380.52M | 38.15%308.25M | 12.87%299.06M | 38.39%296.81M | -4.60%1.02B | 32.80%313.47M |
| Operating revenue | 54.50%476.26M | 68.26%503.22M | 58.49%470.41M | 26.44%1.28B | 21.39%380.52M | 38.15%308.25M | 12.87%299.06M | 38.39%296.81M | -4.60%1.02B | 32.80%313.47M |
| Cost of revenue | 26.55%140.27M | 33.05%150.17M | 20.84%151.33M | 8.91%482.05M | -2.33%133.11M | 15.17%110.84M | -0.22%112.87M | 29.15%125.23M | -11.40%442.61M | 18.64%136.28M |
| Gross profit | 70.20%335.99M | 89.61%353.05M | 85.97%319.08M | 39.96%802.59M | 39.63%247.41M | 55.57%197.41M | 22.61%186.19M | 46.02%171.58M | 1.41%573.44M | 46.22%177.19M |
| Operating expense | -4.59%20.48M | 35.89%23.35M | 113.29%28.4M | 6.93%72.89M | 16.40%20.93M | 46.26%21.47M | 3.28%17.19M | -29.45%13.32M | 9.62%68.17M | -9.09%17.98M |
| Selling and administrative expenses | 0.09%18.61M | 28.93%20.4M | 125.55%24.78M | 5.49%61.57M | 5.56%16.16M | 48.89%18.6M | 12.14%15.83M | -33.23%10.99M | 9.74%58.37M | -5.96%15.31M |
| -General and administrative expense | 0.09%18.61M | 28.93%20.4M | 125.55%24.78M | 5.49%61.57M | 5.56%16.16M | 48.89%18.6M | 12.14%15.83M | -33.23%10.99M | 9.74%58.37M | -5.96%15.31M |
| Depreciation amortization depletion | -14.25%307K | -7.78%320K | -10.68%301K | -8.91%1.36M | -13.55%319K | 2.58%358K | -9.40%347K | -13.81%337K | -6.05%1.49M | -6.82%369K |
| -Depreciation and amortization | -14.25%307K | -7.78%320K | -10.68%301K | -8.91%1.36M | -13.55%319K | 2.58%358K | -9.40%347K | -13.81%337K | -6.05%1.49M | -6.82%369K |
| Other taxes | -3.70%156K | -15.86%260K | 48.10%622K | -4.10%1.01M | 23.16%117K | 57.28%162K | 51.47%309K | -35.19%420K | -5.91%1.05M | -48.65%95K |
| Other operating expenses | -40.22%1.41M | 236.84%2.37M | 71.53%2.69M | 23.37%8.96M | 96.28%4.33M | 35.48%2.35M | -63.76%703K | 13.93%1.57M | 15.33%7.26M | -24.34%2.21M |
| Operating profit | 79.32%315.51M | 95.08%329.7M | 83.67%290.68M | 44.42%729.69M | 42.25%226.48M | 56.79%175.95M | 24.99%169.01M | 60.46%158.26M | 0.39%505.27M | 57.00%159.21M |
| Net non-operating interest income (expenses) | 54.34%8.28M | 126.93%7.03M | 71.46%7.37M | -34.32%19.28M | -23.67%6.52M | -36.38%5.36M | -54.65%3.1M | -22.64%4.3M | 3,893.47%29.35M | 232.37%8.54M |
| Non-operating interest income | 43.61%9.72M | 92.33%8.46M | 53.49%8.81M | -28.79%24.83M | -20.06%7.93M | -31.21%6.77M | -46.27%4.4M | -17.21%5.74M | 451.53%34.86M | 151.18%9.91M |
| Non-operating interest expense | 53.52%109K | 52.78%110K | 22.97%91K | 37.20%284K | -10.53%68K | -8.97%71K | 100.00%72K | 335.29%74K | 127.47%207K | 300.00%76K |
| Total other finance cost | -0.08%1.33M | 7.33%1.32M | -1.32%1.35M | -0.72%5.27M | 3.16%1.34M | 0.30%1.33M | -6.76%1.23M | 0.51%1.37M | -3.49%5.3M | -4.57%1.3M |
| Other net income (expenses) | 10,501.43%88.84M | 76.45%1.28M | -188.27%-1.29M | -2,458.57%-104.63M | -4,033.91%-107.65M | -3.68%838K | -86.89%726K | 131.06%1.46M | -97.32%4.44M | -105.23%-2.6M |
| Gain on sale of security | 224.18%2.68M | 43.53%1.04M | -51.30%710K | 83.01%4.28M | 117.35%1.27M | -4.94%827K | 233.03%726K | 119.25%1.46M | 653.55%2.34M | 2,810.00%582K |
| Special income (charges) | --85.72M | ---- | ---- | -2,265.53%-108.86M | ---108.86M | --0 | --0 | ---- | -96.94%5.03M | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --108.86M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Gain on sale of property,plant,equipment | --85.72M | ---- | ---- | --0 | --0 | --0 | --0 | ---- | -96.77%5.03M | --0 |
| Other non-operating income (expenses) | 3,854.55%435K | --239K | ---2M | 98.63%-40K | 98.40%-51K | --11K | ---- | ---- | -457.82%-2.93M | -9,470.59%-3.19M |
| Income before tax | 126.53%412.62M | 95.57%338M | 80.94%296.76M | 19.53%644.34M | -24.10%125.36M | 49.89%182.15M | 17.11%172.83M | 56.49%164.01M | -19.50%539.06M | 7.41%165.15M |
| Income tax | 65.05%45.41M | -9.46%45.73M | 158,540.74%42.78M | 8,047.38%115.2M | 1,232.32%37.21M | 434.71%27.51M | 723.36%50.51M | 99.59%-27K | 177.80%1.41M | 73.44%-3.29M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 137.47%367.22M | 138.94%292.27M | 54.83%253.98M | -1.58%529.14M | -47.67%88.15M | 32.88%154.64M | -13.53%122.32M | 47.27%164.04M | -19.65%537.64M | 1.39%168.44M |
| Net income continuous operations | 137.47%367.22M | 138.94%292.27M | 54.83%253.98M | -1.58%529.14M | -47.67%88.15M | 32.88%154.64M | -13.53%122.32M | 47.27%164.04M | -19.65%537.64M | 1.39%168.44M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 137.47%367.22M | 138.94%292.27M | 54.83%253.98M | -1.58%529.14M | -47.67%88.15M | 32.88%154.64M | -13.53%122.32M | 47.27%164.04M | -19.65%537.64M | 1.39%168.44M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 137.47%367.22M | 138.94%292.27M | 54.83%253.98M | -1.58%529.14M | -47.67%88.15M | 32.88%154.64M | -13.53%122.32M | 47.27%164.04M | -19.65%537.64M | 1.39%168.44M |
| Diluted earnings per share | 137.24%0.809 | 138.52%0.644 | 54.70%0.56 | -1.68%1.167 | -47.85%0.194 | 32.68%0.341 | -13.46%0.27 | 47.15%0.362 | -19.91%1.187 | 1.09%0.372 |
| Basic earnings per share | 137.35%0.807 | 139.03%0.643 | 54.42%0.559 | -1.77%1.165 | -47.85%0.194 | 32.30%0.34 | -13.78%0.269 | 47.15%0.362 | -19.81%1.186 | 1.36%0.372 |
| Dividend per share | 6.45%0.165 | 6.45%0.165 | 6.45%0.165 | 3.33%0.62 | 3.33%0.155 | 3.33%0.155 | 3.33%0.155 | 3.33%0.155 | 0.00%0.6 | 0.00%0.15 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.